Neostigmine Methylsulfate
NDC 23155-517, Neostigmine Methylsulfate, injection, from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
- Product NDC
- 23155-517
- Status
- Listed
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208230
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23155-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE.5 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23155-517-41 | 23155051741 | 10 VIAL in 1 CARTON (23155-517-41) / 10 mL in 1 VIAL (23155-517-31) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9cc2bfa1-c968-4d01-8162-2ef188974164
Use it
Look up 23155-517 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23155-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23155-517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.